Mark McCann

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

David McHugh, Cynthia A. Cameron, José E. Abdenur et al. · Genetics in Medicine · 2011 · 349 citations · Full text

Metabolic Syndrome, Newborn Screening, Metabolic Disorder +10

Improved Specificity of Newborn Screening for Congenital Adrenal Hyperplasia by Second-Tier Steroid Profiling Using Tandem Mass Spectrometry

Jean M. Lacey, Carla Minutti, Mark J Magera et al. · Clinical Chemistry · 2004 · 212 citations · Full text

Steroid Profiling by Tandem Mass Spectrometry Improves the Positive Predictive Value of Newborn Screening for Congenital Adrenal Hyperplasia

Carla Minutti, Jean M. Lacey, Mark J Magera et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 150 citations

Gynecology, Blood Spots, Dermatology +20

Sensitivity of Dried Blood Spot Testing for Detection of Congenital Cytomegalovirus Infection

Sheila C. Dollard, Maggie Dreon, Nelmary Hernandez-Alvarado et al. · JAMA Pediatrics · 2021 · 132 citations · Full text

Immunohematology, Congenital Cytomegalovirus Infection, Neonatology +19

Enhanced interpretation of newborn screening results without analyte cutoff values

Gregg Marquardt, Robert J. Currier, David McHugh et al. · Genetics in Medicine · 2012 · 123 citations · Full text

Early Diagnosis, Newborn Screening, Neonatology +8